Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
<p><strong>Background</strong></p> Doxycycline is often used for treating COVID-19 respiratory symptoms in the community despite an absence of evidence from clinical trials to support its use. We aimed to assess the efficacy of doxycycline to treat suspected COVID-19 in the c...
Үндсэн зохиолчид: | Butler, CC, Yu, L-M, Dorward, J, Gbinigie, O, Hayward, G, Saville, BR, Van Hecke, O, Berry, N, Detry, MA, Saunders, C, Fitzgerald, M, Harris, V, Djukanovic, R, Gadola, S, Kirkpatrick, J, Ogburn, E, Patel, MG, de Lusignan, S, Evans, PH, Thomas, NPB, Hobbs, FDR |
---|---|
Бусад зохиолчид: | PRINCIPLE Trial Collaborative Group |
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Elsevier
2021
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
-н: PRINCIPLE Trial Collaborative Group, зэрэг
Хэвлэсэн: (2021) -
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial
-н: Yu, L-M, зэрэг
Хэвлэсэн: (2021) -
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
-н: Yu, L-M, зэрэг
Хэвлэсэн: (2021) -
Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
-н: PRINCIPLE Trial Collaborative Group, зэрэг
Хэвлэсэн: (2021) -
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
-н: Dorward, J, зэрэг
Хэвлэсэн: (2022)